等待開盤 11-26 09:30:00 美东时间
+1.230
+0.68%
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
今天 10:07
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
11-25 10:27
Mizuho analyst Vikram Malhorta maintains AvalonBay Communities (NYSE:AVB) with a Neutral and lowers the price target from $199 to $191.
11-24 22:16
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
AvalonBay Communities Inc's (NYSE:AVB) short interest as a percent of float has...
11-14 03:00
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
Wells Fargo analyst James Feldman maintains AvalonBay Communities (NYSE:AVB) with a Overweight and lowers the price target from $213 to $193.
11-10 22:35
今日重点评级关注:瑞银:维持Syndax Pharmaceuticals"买入"评级,目标价从35美元升至38美元;HC Wainwright & Co.:维持Benitec Biopharma"买入"评级,目标价从28美元升至35美元
11-05 10:35
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
11-04 10:31
AvalonBay Communities (NYSE:AVB) lowers FY2025 FFO guidance from $11.19-$11.59 to $11.15-$11.35 vs $11.39 analyst estimate..
10-30 04:19